Cellestia (private company)
See something wrong or missing? Let us know
Offices:Basel
Industry:BiotechHealth servicesManufacturing
Business model:B2B
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Cellestia
Name | Criteria | |
---|---|---|
![]() |
i3 Membrane
53%
|
|
![]() |
Biograil
53%
|
|
![]() |
Synendos Therapeutics
53%
|
|
![]() |
Telomere Therapeutics
53%
|
|
![]() |
Memo Therapeutics
53%
|
|
![]() |
Sarcura
53%
|
|
![]() |
ResoTher Pharma
53%
|
|
![]() |
NuVision Biotherapies
53%
|
|
![]() |
Brinter
53%
|
|
![]() |
Biomes
53%
|
|